SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

A room full of agents is not a software factory

Why are AI providers lowering prices even as usage expands?

OpenAI hit pause, attackers haven’t. Here’s what security leaders must do next

Claude Code creator's prompting formula: Say what you want and let AI figure out the rest

Buzz

Most popular

Daily

Weekly

1

Israel loses $1 billion Apache deal after failing to find $288 million in funding

2

Nvidia hits record $5.65 trillion as SpaceX seeks $40 billion to buy its AI chips

3

Israeli startup raises $5 million to rethink one of surgery's most invasive procedures

4

Israel to end private recruitment of construction workers from India and Sri Lanka

5

Foreign investors are pulling back from Israeli stocks as appetite for banks collapses

Quris

7 stories about Quris

Michel Yossi Quris

Quris-AI appoints Michel Vounatsos and Yossi Ben Amram in key roles

Vounatsos was appointed Board member and Ben Amram was appointed President, respectively.

ד״ר צחון בנטואיץ׳ מייסד משותף של קיוריס Quris AI

Pharma giant Merck expands collaboration with Quris-AI

28.09.23|Meir Orbach

This follows the successful initial collaboration, a preclinical study to assess Quris-AI’s ability to predict drug toxicity in comparison to traditional in vitro and in vivo approaches

יוסי הרן צחון בנטואיץ Quris

SoftBank leads $9 million investment in AI pharma startup Quris

20.12.22|Meir Orbach

The Israeli startup expanded its Seed funding to $37 million and plans to use the additional investment to advance its Bio-AI clinical-prediction platform that simulates clinical trials

Isaac Bentwich BiblioTech

CTech’s Book Review: Breaking down the barriers to set you free

13.07.22|Isaac Bentwich

Isaac Bentwich, Founder and CEO of Quris Technologies, shares insights after reading “Untethered Soul” by Michael A. Singer

מימין אהרון צ'חנובר יו"ר הוועדה המדעית בקיוריס והמנכ"ל צחון בנטואיץ'

Pharma giant Merck inks deal with Israel’s Quris for clinical safety prediction

09.02.22|Meir Orbach

The Israeli company which develops predictive technology based on artificial intelligence has signed an agreement worth tens of millions of dollars to test drugs by the pharma giant

Quris Isaac Bentwich

Quris closes record $28 million Seed funding for AI drug development platform

11.01.22|Meir Orbach

The Israeli startup uses AI-powered miniaturized “patients-on-a-chip” to avoid the risks and costs of failed clinical trials and eliminate the reliance on ineffective animal testing

Quris Isaac Bentwich

Quris raises $9 million in Seed for its clinician prediction AI platform

21.10.21|James Spiro

The announcement coincides with the launch of its platform via a partnership with the NYSCF Research Institute.